Covered recipient · General Payments record
DEREK E PYNE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2023
$517.63
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $137.58 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $57.95 | 3 |
| GlaxoSmithKline, LLC. | $31.50 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.31 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.63 | 1 |
| Novo Nordisk AS | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.87 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998173831 | CMS |
| ABBVIE INC. | $14.96 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998173833 | CMS |
| ABBVIE INC. | $23.12 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998173835 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.31 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996494869 | CMS |
| GlaxoSmithKline, LLC. | $17.16 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003418917 | CMS |
| GlaxoSmithKline, LLC. | $14.34 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003418475 | CMS |
| Novo Nordisk Inc | $14.19 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002623875 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.63 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057498371 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.